Collagen Peptides
Evidence Fact Sheet
Hydrolyzed Type I/II/III
Hydrolyzed collagen peptides (Type I/II/III) supply Pro-Hyp/Hyp-Gly dipeptides plus glycine, proline and hydroxyproline that may signal dermal fibroblasts and chondrocytes. Typical research doses run 2.5-10 g/day (40 mg/day UC-II for joint trials). FDA GRAS; EFSA rejected collagen skin claims in 2011. Evidence is strongest for skin, with honest null findings for muscle protein synthesis.
Also known as: Hydrolyzed collagen · Collagen hydrolysate · Bioactive collagen peptides (BCP)
Overview
Collagen peptides are hydrolyzed (enzymatically cleaved) animal-derived collagen — bovine, marine or porcine — yielding low-molecular-weight bioactive di- and tripeptides such as Pro-Hyp and Hyp-Gly that are absorbed intact and are hypothesized to signal dermal fibroblast collagen synthesis, chondrocyte matrix turnover, and to supply glycine/proline/hydroxyproline for connective-tissue repair. Most clinical research uses 2.5-10 g/day of hydrolyzed peptides, with a distinct 40 mg/day undenatured Type II (UC-II) form studied for joint comfort. In the US they are regulated as a GRAS dietary-supplement ingredient under DSHEA (structure/function claims only); the EFSA rejected collagen-specific skin health claims in 2011, ANVISA does not authorize a functional claim, and China treats gelatin/collagen peptides as ordinary food. They are animal-derived (not vegan-compatible) and generally well tolerated, with source-protein allergy the main caution.
Mechanism of Action
Bioactive dipeptide/tripeptide absorption (Pro-Hyp · Hyp-Gly) · Dermal fibroblast collagen synthesis stimulation · Chondrocyte matrix turnover signaling · Glycine + proline + hydroxyproline amino acid supply
Body systems: Skin & Connective Tissue · Musculoskeletal · CONNECTIVE
Evidence-Based Benefits
Each benefit below is anchored to a specific PubMed-indexed study. Effect sizes, sample sizes, and p-values are reported as published; no values are inferred. Honest negatives and null results are kept alongside the positive findings, and disease-research populations are described as such — Collagen Peptides is not characterized as a treatment for any disease.
Skin Hydration and Elasticity
Meta-analysis supported- 26 RCTstrials pooled
- 1,721 patientsparticipants
- Z = 4.94, p < 0.00001hydration · overall effect
The largest pooled analysis to date combined 26 randomized controlled trials in 1,721 participants and found that oral hydrolyzed collagen significantly improved both skin hydration and elasticity versus placebo. The abstract reports a test for overall effect rather than a single mean-difference number, so the magnitude is summarized as a Z statistic with p-value.
Reported effect: Hydration: test for overall effect Z = 4.94, p < 0.00001; Elasticity: Z = 4.49, p < 0.00001 (26 RCTs, 1,721 patients)
“HC supplementation significantly improved skin hydration (test for overall effect: Z = 4.94, p < 0.00001) compared to the placebo group. ... HC supplementation significantly improved...elasticity (test for overall effect: Z = 4.49, p < 0.00001) compared to the placebo group.”
Source: PMID 37432180 · Pu 2023 · Nutrients
Wrinkle Reduction and Dermal Matrix Synthesis
RCT supported- 20%eye wrinkle volume ↓ · 8wk
- 65%procollagen type I ↑
- 114 women2.5 g/day · 8 weeks
In a double-blind RCT of 114 women taking 2.5 g/day of a specific bioactive collagen peptide for 8 weeks, eye-wrinkle volume fell about 20% versus placebo, and skin-biopsy measures showed higher procollagen type I and elastin content — giving a mechanistic readout consistent with stimulated dermal matrix synthesis.
Reported effect: Eye wrinkle volume reduced ~20% vs placebo after 8 weeks (p < 0.05); procollagen type I +65% and elastin +18% in BCP group vs placebo (n = 114, 2.5 g/day)
“The ingestion of the specific BCP used in this study promoted a statistically significant reduction of eye wrinkle volume (p < 0.05) in comparison to the placebo group after 4 and 8 weeks (20%) of intake. ... After 8 weeks of intake a statistically significantly higher content of procollagen type I (65%) and elastin (18%) in the BCP-treated volunteers compared to the placebo-treated patients was detected.”
Source: PMID 24401291 · Proksch 2014 · Skin Pharmacol Physiol
Joint Comfort / Knee Osteoarthritis (UC-II)
RCT supported- 191 volunteersUC-II 40 mg/day
- p = 0.002WOMAC total vs placebo · d180
- p = 0.0003WOMAC pain vs placebo
A multicenter double-blind RCT of 191 knee-osteoarthritis volunteers tested undenatured type II collagen (UC-II) 40 mg/day — a distinct low-dose form from hydrolyzed peptides. At day 180 the UC-II group showed a significant reduction in overall WOMAC score versus placebo, with significant improvements across the pain, stiffness and physical-function subscales.
Reported effect: At day 180 UC-II 40 mg/day reduced overall WOMAC vs placebo (p = 0.002); subscales pain p = 0.0003, stiffness p = 0.004, physical function p = 0.007 (n = 191)
“At day 180, the UC-II group demonstrated a significant reduction in overall WOMAC score compared to placebo (p = 0.002) ... Pain: p = 0.0003 vs. placebo; Stiffness: p = 0.004 vs. placebo; Physical function: p = 0.007 vs. placebo”
Source: PMID 26822714 · Lugo 2016 · Nutr J
Joint Function and Pain in Active Adults
RCT supported- p = .031, ηp2 = .096ADLs · 10 g/d · 6 mo
- p = .037, ηp2 = .164pain · 10 g/d
- p = .017, ηp2 = .309mental component score
In a double-blind RCT of active adults, 10 g/day collagen peptides over 6 months improved activities-of-daily-living and pain scores, while quality-of-life mental and physical component scores improved over 3-9 months. The pain benefit appeared only in high-frequency exercisers (>180 min/week) and the physical-component gain only in females, so effects were conditional rather than uniform.
Reported effect: 10 g/d CP over 6 months: ADLs p = .031 (ηp2 = .096), pain p = .037 (ηp2 = .164, only in >180 min/week exercisers); VR-12 mental component p = .017 (ηp2 = .309); physical component improved with 20 g/d only in females (p = .013)
“Improvements in ADLs (p = .031, ηp2 = .096)...were observed with 10 g/d CP over 6 months ... pain (p = .037, ηp2 = .164) ... although pain only improved in high frequency exercisers (>180 min/week) ... VR-12 mental component scores (MCS) improved with 10 g/d of CP over 3-9 months (p = .017, ηp2 = .309) ... physical component scores (PCS) improved with 20 g/d of CP over 3-9 months, but only in females (p = .013, ηp2= .582)”
Source: PMID 37551682 · Kviatkovsky 2023 · J Int Soc Sports Nutr
Bone Mineral Density (Postmenopausal Women)
RCT supported- p = 0.003T-score femoral neck vs control
- p = 0.030T-score spine vs control
- p = 0.007P1NP bone formation marker
In a randomized controlled study, specific collagen peptides increased bone mineral density T-scores at the spine and femoral neck relative to control in postmenopausal women, accompanied by a rise in the bone-formation marker P1NP, while the bone-resorption marker CTX-1 rose in the control group instead.
Reported effect: T-score spine: SCP +0.1 ± 0.26 vs control -0.03 ± 0.18 (ANCOVA p = 0.030); T-score femoral neck: SCP +0.09 ± 0.24 vs control -0.01 ± 0.19 (p = 0.003); P1NP increased in SCP group (p = 0.007)
“T-score spine: SCP +0.1 ± 0.26; CG -0.03 ± 0.18; ANCOVA p = 0.030 ... T-score femoral neck: SCP +0.09 ± 0.24; CG -0.01 ± 0.19; ANCOVA p = 0.003 ... P1NP increased significantly in the SCP group (p = 0.007), whereas CTX 1 increased significantly in the control group (p = 0.011)”
Source: PMID 29337906 · König 2018 · Nutrients
Muscle Mass and Strength in Sarcopenia
RCT supported- +4.2 vs +2.9 kgfat-free mass · CP vs PL · P<0.05
- +16.5 vs +7.3 Nmquadriceps strength · P<0.05
- 53 men · 15 g/day+ resistance training
In 53 elderly sarcopenic men, 15 g/day collagen peptides combined with 12 weeks of resistance training produced significantly greater gains in fat-free mass and quadriceps strength, and greater fat-mass loss, than training plus placebo. Note the comparator already trained, so the result is an additive benefit on top of exercise.
Reported effect: Fat-free mass +4.2 (SD 2.31) kg with CP vs +2.9 (SD 1.84) kg placebo; isokinetic quadriceps strength +16.5 (SD 12.9) Nm vs +7.3 (SD 13.2) Nm; fat mass -5.4 vs -3.5 kg (all P<0.05, n = 53, 15 g/day)
“FFM (TG +4·2 (sd 2·31) kg/PG +2·9 (sd 1·84) kg; P<0·05) ... FM (TG -5·4 (sd 3·17) kg/PG -3·5 (sd 2·16) kg; P<0·05) ... IQS (TG +16·5 (sd 12·9) Nm/PG +7·3 (sd 13·2) Nm; P<0·05)”
Source: PMID 26353786 · Zdzieblik 2015 · Br J Nutr
Tendon Stiffness and Explosive Strength
RCT supported- d = 0.378Achilles tendon stiffness · p<0.001
- d = 0.525rate of force development · p<0.001
- 50 males · 10 g/day · 16 wkvs placebo
A 16-week double-blind RCT in 50 sedentary young men found that 10 g/day collagen peptides significantly increased medial gastrocnemius and Achilles tendon stiffness and explosive strength (normalized rate of force development), with no significant change in the placebo group — pointing to connective-tissue stiffening even without a training program built around it.
Reported effect: CP group: medial gastrocnemius stiffness (p < 0.001, Cohen's d = 0.594), Achilles tendon stiffness (p < 0.001, d = 0.378), normalized RTD (p < 0.001, d = 0.525); no significant change in placebo (n = 50, 10 g/day, 16 weeks)
“The CP group exhibited significant increases in MG stiffness (P < 0.001, Cohen's d = 0.594) and Achilles tendon stiffness (P < 0.001, Cohen's d = 0.378), whereas no significant changes occurred in the PLA group. ... Similarly, the normalized RTD increased significantly in the CP group (P < 0.001, Cohen's d = 0.525) but not in the PLA group.”
Source: PMID 40623147 · Miyamoto 2025 · Med Sci Sports Exerc
Nail Growth and Brittleness
RCT supported- +12%nail growth rate
- -42%frequency of broken nails
- 2.5 g/day · 24 wkn = 25 · open-label
In an open-label clinical study of 25 participants, 2.5 g/day bioactive collagen peptides for 24 weeks increased nail growth rate and reduced broken-nail frequency, with most participants reporting global improvement in brittle nails. Because this trial was open-label rather than placebo-controlled, it carries less weight than the blinded RCTs above.
Reported effect: Nail growth rate +12%; frequency of broken nails -42%; 64% of participants achieved global clinical improvement in brittle nails (n = 25, 2.5 g/day, 24 weeks, open-label)
“Bioactive collagen peptides treatment promoted an increase of 12% nail growth rate ... a decrease of 42% in the frequency of broken nails ... 64% of participants achieved a global clinical improvement in brittle nails”
Source: PMID 28786550 · Hexsel 2017 · J Cosmet Dermatol
Muscle Protein Synthesis (Honest Negative)
Null / no benefit RCT supported- P>0.05no rise in MPS vs placebo
- n=25young men · resistance training
- 2×15 g/dcollagen peptides
A controlled trial in 25 young men found that collagen peptides at 2 × 15 g/day did NOT raise myofibrillar or muscle connective-tissue protein synthesis rates above placebo during a week of intense resistance training. This is a key honest negative: collagen's amino-acid profile is low in leucine, so it does not drive muscle-building synthesis the way whey does.
Reported effect: Myofibrillar protein synthesis 1.34±0.23 with no increase vs placebo; muscle connective-tissue synthesis 1.97±0.47 (collagen) vs 2.00±0.27 (placebo), P>0.05; n=25
Source: PMID 39086044 · Kirmse 2024 · Med Sci Sports Exerc
Collagen vs Whey for Older-Adult Muscle (Honest Negative)
Null / no benefit RCT supported- 1.59 %/dwhey MPS · p<0.001 vs RDA
- 1.59 %/dpea MPS · p<0.001 vs RDA
- unchangedcollagen · 31 older males
A double-blind RCT in 31 older males (72 ± 4 y) compared 50 g/day of extra whey, pea or collagen protein. Whey and pea each significantly raised integrated myofibrillar protein synthesis above the RDA control, but collagen left it unchanged — reinforcing that collagen is not an effective anabolic protein source for combating age-related anabolic resistance.
Reported effect: Integrated MPS increased with whey (1.59 ± 0.11 %/d, P < 0.001) and pea (1.59 ± 0.14 %/d, P < 0.001) vs RDA; remained unchanged with collagen (n = 31, 50 g/day added protein)
“Integrated MPS was increased during supplemental with whey (1.59 ± 0.11 %/d; P < 0.001) and pea (1.59 ± 0.14 %/d; P < 0.001) when compared with RDA; however, it remained unchanged with collagen.”
Source: PMID 38762187 · McKendry 2024 · Am J Clin Nutr
Wound Healing and Dermatological Applications
Emerging / indexedA systematic review of 11 studies and 805 patients reported that oral collagen supplements show promising short- and long-term signals for wound healing and skin aging, alongside increased skin elasticity, hydration and dermal collagen density. The review reports direction qualitatively without a single pooled effect-size number, so this is a lower-certainty, emerging area for wound healing specifically.
Effect size: this study reports the direction of the finding but does not state a specific numeric effect size, so none is given here rather than estimated.
“Preliminary results are promising for the short and long-term use of oral collagen supplements for wound healing and skin aging. Oral collagen supplements also increase skin elasticity, hydration, and dermal collagen density.”
Source: PMID 30681787 · Choi 2019 · J Drugs Dermatol
Dosage (research context · not a recommendation)
2.5-10 g/day hydrolyzed collagen peptides; 40 mg/day UC-II undenatured Type II for joint comfort RCTs
Regulatory Status · 4 Markets
- US · FDA
- GRAS · DSHEA dietary supplement; structure/function claims permitted
- EU · EFSA
- No authorized health claim (collagen-specific claims rejected 2011)
- CN · China
- Managed as a conventional food in China — gelatin and collagen peptides are ordinary food ingredients, not listed as New Food Raw Materials (novel food); collagen also appears in registered health foods.
- BR · ANVISA
- RDC 243/2018 dietary supplement · IN 28/2018 alegação funcional not authorized for collagen
Safety
Generally well tolerated; bovine/marine/porcine source allergens possible; vegan-incompatible (animal-derived)
Related
Goals: skin-beauty · joint-bone · athletic-performance
Lifestyles: senior-60-plus · menopause · athletic-performance
References
PubMed-indexed citations anchoring the benefit findings above. Effect sizes are reported as published.
- PMID 37432180 · Pu 2023 · Nutrients — Skin Hydration and Elasticity
- PMID 24401291 · Proksch 2014 · Skin Pharmacol Physiol — Wrinkle Reduction and Dermal Matrix Synthesis
- PMID 26822714 · Lugo 2016 · Nutr J — Joint Comfort / Knee Osteoarthritis (UC-II)
- PMID 37551682 · Kviatkovsky 2023 · J Int Soc Sports Nutr — Joint Function and Pain in Active Adults
- PMID 29337906 · König 2018 · Nutrients — Bone Mineral Density (Postmenopausal Women)
- PMID 26353786 · Zdzieblik 2015 · Br J Nutr — Muscle Mass and Strength in Sarcopenia
- PMID 40623147 · Miyamoto 2025 · Med Sci Sports Exerc — Tendon Stiffness and Explosive Strength
- PMID 28786550 · Hexsel 2017 · J Cosmet Dermatol — Nail Growth and Brittleness
- PMID 39086044 · Kirmse 2024 · Med Sci Sports Exerc — Muscle Protein Synthesis (Honest Negative)
- PMID 38762187 · McKendry 2024 · Am J Clin Nutr — Collagen vs Whey for Older-Adult Muscle (Honest Negative)
- PMID 30681787 · Choi 2019 · J Drugs Dermatol — Wound Healing and Dermatological Applications
Frequently Asked Questions
1. What is the strongest evidence for collagen peptides?
Skin. The largest meta-analysis (Pu 2023, PMID 37432180) pooled 26 randomized controlled trials in 1,721 participants and found oral hydrolyzed collagen significantly improved skin hydration (overall effect Z = 4.94, p < 0.00001) and elasticity (Z = 4.49, p < 0.00001) versus placebo. A mechanistic RCT (Proksch 2014) adds biopsy evidence of about 20% lower eye-wrinkle volume and higher procollagen type I content.
2. Does collagen help build muscle?
The evidence says no — this is collagen's best-documented honest negative. In young trained men, 2 × 15 g/day did not raise myofibrillar or muscle connective protein synthesis above placebo (Kirmse 2024, P > 0.05). In older males, whey and pea raised muscle protein synthesis (1.59 %/d, P < 0.001) but collagen left it unchanged (McKendry 2024). Collagen is low in leucine, so it is not an effective muscle-building protein source.
3. What dose is used in research?
Most clinical studies use 2.5-10 g/day of hydrolyzed collagen peptides — for example 2.5 g/day in the Proksch 2014 skin trial and the Hexsel 2017 nail study, and 10 g/day in the Miyamoto 2025 tendon and Kviatkovsky 2023 joint trials. The undenatured Type II collagen (UC-II) studied for knee osteoarthritis (Lugo 2016) uses a much smaller 40 mg/day. This describes doses used in research, not a recommendation.
4. Can collagen support joints and bones?
There are positive signals. For joints, UC-II 40 mg/day reduced overall WOMAC osteoarthritis scores versus placebo at day 180 (Lugo 2016, p = 0.002), and 10 g/day improved daily-function and pain scores in active adults (Kviatkovsky 2023), though some benefits appeared only in subgroups. For bone, specific collagen peptides raised femoral-neck and spine BMD T-scores in postmenopausal women (König 2018, p = 0.003 and p = 0.030).
5. Is collagen suitable for vegans, and is it safe?
No — collagen peptides are animal-derived (bovine, marine or porcine) and are not vegan-compatible. They are generally well tolerated; the main caution is allergy to the source protein. In the US they are a GRAS dietary-supplement ingredient permitting structure/function claims only. Note that the EFSA rejected collagen-specific skin health claims in 2011 and ANVISA does not authorize a functional claim, so regulatory acceptance lags the trial data.
6. What about tendons, nails and wound healing?
For tendons, 10 g/day over 16 weeks increased Achilles tendon stiffness and explosive strength versus placebo (Miyamoto 2025, p < 0.001). For nails, an open-label study found a 12% higher growth rate and 42% fewer broken nails (Hexsel 2017) — but it lacked a placebo group, so it is weaker evidence. For wound healing, a systematic review of 11 studies (805 patients) calls results promising but reports them qualitatively without a pooled effect size (Choi 2019), making it an emerging area.
Last evidence review: 2026-05-29